at Zacks.com (Fri, 1:40PM)
Cepheid (CPHD) guides Q3 sales lower, saying revenue is expected to be in the range of $79M to...
Cepheid (CPHD) guides Q3 sales lower, saying revenue is expected to be in the range of $79M to $81M, lower than targeted due to intermittent interruptions in the supply of Xpert cartridge parts. The parts availability is being addressed and Cepheid is working aggressively to ship orders. However, the company currently expects to exit the quarter with more than $5M in backorders which it expects to be fulfilled by the end of October. Shares -3% AH.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Investor's Business Daily (Jan 14, 2015)
at Nasdaq.com (Jan 6, 2015)
at Zacks.com (Dec 30, 2014)
at Benzinga.com (Dec 18, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs